Global Apheresis Market Analysis Sample Report

Global
Apheresis
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of Global Apheresis Market and
a forecast for its development in the medium and long term. It provides a
comprehensive overview of the market value, dynamics, segmentation,
characteristics, main players, trends and insights, growth and demand
drivers, challenges & future outlook, etc. This is one of the most
comprehensive reports about the Global Apheresis Market, and offers
unmatched value, accuracy, and expert insights

Table of
Contents
• Market Overview
• Growth Drivers & Restraints
• Market Segmentation
• Major Market Share
• Competitive Landscape
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Future Opportunities
• Conclusion

4 A Sample Report on Global Apheresis Market I Confidential
Table of Contents
1. Global Apheresis Market Overview……………………………..…………..…………………..................................................................08
1.1 Introduction
1.2 Market size and forecast
2. Market Growth Drivers and Restraints …………………………………………………………………….…………………………....…….11
2.1 Market Growth Drivers
2.1.1 Growing demand of different components of blood
2.1.2 Favorable reimbursement policies and funding for Apheresis
2.1.3 Increasing number of complex surgical procedures
2.1.4 Rising cases of neurology, oncology and rare diseases
2.1.5 Increasing demand of source plasma from biopharma companies
2.2 Market Restraints
2.2.1 High cost of apheresis devices and therapeutic apheresis procedures
2.2.2 Fewer blood donations due to lack of awareness and sensitivity among individuals
2.2.3 Stringent donor recruitment criteria
3. Disease Epidemiology……….……………………………………………………………………………..………….……………..…….…….19
3.1 Neurology
3.2 Oncology
3.3 Rare Diseases
3.4 Genetic Disorders

Table of Contents (continued)
4. Apheresis Market Segmentation………………..……………………………………..………….….…………..……………………….....….21
4.1 By Product
4.2 By End User
4.3 By Component
4.4 By Geography
5. Apheresis Market Share ……………………………………………………….………..………………………………………………....…….29
5.1 Market Analysis, Insights and Forecast - By Revenue
6. Competitive Landscape……………….…………………………………………………….………………….…………….…………..……....31
6.1 Major companies for Global Apheresis Market
6.2 Key Player Market Share
7. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials) ….………………...…………………...34
6.1 Fresenius
6.2 Terumo
6.3 Haemonetics
6.4 Macopharma
6.5 Nigale
6.6 Scinomed
6.7 B-Braun
6.6 Asahi Kasei
6.7 Cerus

Table of Contents (continued)
8. Access and Reimbursement Scenario……………………………………………………………………………….……………………….53
8.1 Key market access considerations
8.2 General reimbursement environment
9. Factors Driving Future Growth…………..………………………………………………………………..………...……...….......................56
9.1 Key Industry Developments of Apheresis Market
9.2 Ongoing clinical trials for Apheresis
10. Conclusion…………………………………………………………………………………………………………………….………………….59

Global Apheresis Market Analysis
1. Overview

1.1 Apheresis is the process of separating blood into its components
▪ Apheresis involves removing whole blood from a donor or
patient by passing it through a medical device and
separating the blood into individual components so that
one particular component can be removed
▪ The remaining blood components then are re-introduced
back into the bloodstream of the patient or donor
▪ Used for collection of donor blood components and for
the treatment for certain medical conditions
▪ Process takes two to four hours and is similar to a regular
blood donation
▪ Involves laboratory medicine, clinical hematology
laboratory, pediatric hematology and oncology

1.2 Global Apheresis Market: Market Size and Forecast Overview
The Global Apheresis Market will experience sizable growth over the forecast period, increasing from $3.6 Bn in 2022 to over $6.4
Bn in 2030 growing at a CAGR of 8%
▪ Growth in the market will be largely driven by the rising prevalence of
chronic diseases, growing number of trauma and injury cases,
increasing demand for source plasma and blood components and the
increasing number of complex surgical procedures
▪ Geographically, North America is accounted to hold a significant
market share in the global apheresis market, followed by Europe, Asia
Pacific, Latin America and the Middle East and Africa
Key Findings
Key Players

2. Growth Drivers and Growth Restraints

Snapshot of Market Growth Drivers And Restraints
Favorable
reimbursement
policies and
funding for
Apheresis
High cost of apheresis devices
and therapeutic apheresis
procedures
Impact
Impact
Market
Drivers
Market
Restraints
Increasing
number of
complex
surgical
procedures
Growing
demand of
different
components of
blood
Increasing demand
of source plasma
from biopharma
companies
Rising cases of
neurology, oncology and
rare diseases and the
growing demand of
trauma and injury cases
Fewer blood donations using
apheresis due to lack of
awareness
Stringent donor recruitment
criteria

Market Growth Drivers
2.1.1 Growing demand of different components of blood
The global demand for blood and blood components is on the rise. In the US alone, approximately 44,000 units of
blood are required every day in hospitals and emergency treatment facilities for the treatment of patients suffering
from accident/trauma-related injuries, cancer, and other diseases
Around 21 million units of blood components are transfused in the US every year; whereas, only 13.6 million units of
whole blood and red blood cells are collected yearly in the country
Content
Content

Market Growth Drivers (continued)
Reimbursement policies governing apheresis procedures are quite favorable in developed countries such as the US,
Germany, Italy, and Japan
According to the Centers for Medicare and Medicaid Services (CMS) and American Society for Apheresis (ASFA),
the reimbursement for various apheresis procedures and devices was expected to increase by 5–7%
Content
Content
2.1.2 Favorable reimbursement policies and funding for Apheresis

Over the years, the importance of blood components in treating certain diseases or conditions has been recognized.
Additionally, huge volume of blood and its components are required to manage major blood loss occurring due to
hemorrhages from trauma or surgery
Various chronic diseases have an associated risk of organ failure in affected patients. Such critical cases of organ
failure require organ transplant surgeries. The number of such surgeries is expected to increase in the coming years
as a result of the growth in the prevalence of chronic diseases. This, in turn, is estimated to increase the demand for
blood and blood components during the forecast period
Content
Content
2.1.3 Increasing number of complex surgical procedures

Urbanization, changing lifestyles, and changing food habits have led to an increase in the number of
chronic diseases, such as oncology, cardiovascular disease (CVD), neurological disorders, diabetes, renal disorders,
digestive disorders, rare diseases, etc
According to the American Heart Association, the prevalence of CVD in the US increased from 36.9% in 2010 to
38.7% by 2020 and is further expected to increase to 40.5% by 2030
In cases of trauma and injury uncontrolled haemorrhage is one of the biggest reasons of death and Apheresis is
used to compensate the loss of blood which has a success rate of about 97%
Content
2.1.4 Rising cases of neurology, oncology and rare diseases and the growing demand of trauma
and injury cases

Source plasma is collected from healthy, voluntary donors through a process called plasmapheresis. Biopharma companies
produce plasma-derived products from collected raw plasma and these are used in the treatment of various diseases such as
hemophilia A and B, Von Willebrand Disease, and other bleeding diseases
In order to meet the growing demand for plasma-derived products, biopharmaceutical companies have increased their
processing/fractionation capacities in the past decade
Content
Content
2.1.5 Increasing demand of source plasma from biopharma companies

2.2.1 High cost of apheresis devices &
therapeutic apheresis procedures
2.2.2 Fewer blood donations using apheresis
due to lack of awareness
▪ Despite the increasing demands for blood and its
products, some people, especially the youth, have little
interest in donating blood
▪ Globally, around 112.5 million units of donated blood are
collected every year.
▪ Nearly half of these are collected in high-income
countries and the average blood donation rate is more
than 9 times greater in high-income countries than in
low-income countries.
▪ Particularly, Sub-Saharan Africa faces great challenges
not only in the shortage of blood but also in the safety of
blood
▪ For instance, in the United States, the cost of
an apheresis procedure is approximately USD
2500 per treatment, which is very high
▪ An investment of USD 19,000 to USD 32,000
for a blood cell separator is the initial cost for
setting up the machine and disposable sets
produced by manufacturers will vary between
USD 40 and USD 90 per treatment
▪ Replacement fluids (at an average volume of
2.8 litres), such as albumin or fresh frozen
plasma, make up the remainder of the costs,
running USD 125 to USD 600 per treatment
2.2 Market Restraints

3. Epidemiology

3. Apheresis has several applications across chronic diseases
3.1 Neurology 3.2 Oncology 43.3 Rare Diseases
3.4 Genetic
Disorders
Acute Guillain–Barré
syndrome
Chronic inflammatory
demy-elinating
polyneuropathy
Polyneuropathy associated
with paraproteinaemias
Breast Cancer
Colon Cancer
Leukemia
Lymphoma
Multiple Myeloma
Thymoma
Myasthenia Gravis
Thrombotic
thrombocytopenic purpura
Sickle Cell Disease

4. Market Segmentation

4. Snapshot of Apheresis Market Segmentation
Market Segmentation
By End User
By Product
Disposables Devices
By Component
Platelets
Leukocytes
Plasma
Therapeutic
Apheresis
Other End Users
Hospitals
Blood Centers
By Geography
Europe
APAC
North America
RoW

4.1 Market Segmentation By Product: Disposables (Volume Market)
Globally xx million Disposables were utilized across different procedures for apheresis
Globally Volume of Disposables used for Apheresis (segregated by procedure type) in 2022
Total
xx
Platelet Apheresis
Red Blood Cell
Apheresis
Plasmapheresis
Therapeutic
Apheresis
▪ Key Insights
Sample
Hospitals Dialysis Service Providers

Market Segmentation By Product: Disposables (Value Market)
Globally $yy billions of revenue was generated from xx million units of disposables, which made up ~85% of
the global apheresis market
Platelet Apheresis
Red Blood Cell
Apheresis
Plasmapheresis
Therapeutic Apheresis
Hospitals Dialysis Service Providers
Total
xx
▪ Key Insights
Globally Revenue generated by Disposables used for Apheresis (segregated by procedure type) in 2022
Sample

Market Segmentation By Product: Disposables (Geographical Split)
Apheresis Disposables Market Revenues (by Major
Regions) in $B, 2022
# of Apheresis Disposables Utilized Globally (by
Major Regions), 2022
Total
North America Europe APAC RoW
xx
Total
xx
▪ Key Insights
Sample
43% of the total global revenues from disposables is from North America

Market Segmentation By Product: Devices (Volume Market)
Globally ~xx thousand devices / machines are
installed for performing apheresis
Total # Devices
Installed Globally
Total # Devices
Replenished in 2020
Globally
▪ Considering a 5 year lifecycle of an Apheresis device, we
assumed that only 20% of the total devices will be actually
replenished in any particular year (2020) for the lifecycle of
entire 5 years
▪ And, thus this 20% of replenished devices will only
contribute to the sales generated through devices in
that single year
▪ Therefore, as ~xx machines / devices were globally installed
for apheresis, only 20% of those were actually replenished
and generated sales
Key Assumptions

Market Segmentation By Product: Devices (Volume & Value Geographical Split)
Apheresis Devices Market Revenues (by Major
Regions) in $B, 2020
# of Apheresis Devices Installed Globally (by Major
Regions), 2020
Total
xx
Total
xx
▪ Key Insights
Sample
40% of the total global revenues from devices is from North America

4.3 Total Global Apheresis Value Market Segmentation By Geography
▪ North America is a major market for apheresis, with
greater share coming from U.S., followed by Canada
▪ Europe contributes to one-third of the total market with major
markets being Germany followed by UK, France and Italy
▪ APAC regions contributes to around one-fifth of the
global market, with major markets being Japan, followed by
China, South Korea and India
▪ Rest of the world brings in 5% of global revenues, with
Brazil being a major contributor
▪ Anticipated growth rates for various geographies are as
follows:
▪ North America: 8.8% - 10.9%
▪ Europe: xx% - xx%
▪ APAC: xx% - xx%
▪ RoW: xx% - xx%
Key Highlights
Global Apheresis Market (by Major Regions) in $B, 2022
Total

5. Market Share

Top Brands Global Apheresis Market
5.1 Global Apheresis Market Share
Key Insights
Global Apheresis Market Share
0
1
2
3
4
5
6
7
8
9
0 1 2 3 4 5
Brand 1
Brand 2
Brand3
Brand 4

6. Competitive Landscape

6.1 Competitive Landscape: Key Players Revenue
(Current and Forecasted)
Major Market Revenue of Top Companies in the Apheresis Market ($Mn)
2020 2021F 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Fresenius Kabi $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Terumo $996M $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Haemonetics $988M $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Macopharma $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Nigale $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Scinomed $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
B-Braun $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Asahi Kasei $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Cerus $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx

6.2 Competitive Landscape: Key Players Market Share
▪ Terumo has a significant global footprint owing to its strong
sales and distribution network. Additionally, strong after-
sale services such as maintenance and re-installation of
instruments gives the firm a competitive advantage over
other players in the apheresis market. The company’s
extensive R&D activities enable it to increase its depth of
capabilities in technologies. Moreover, significant
investments also assist the company in launching
innovative products in the market space
▪ Fresenius has maintained its leading position in the market
through its strong distribution networks across the Asia
Pacific, North America, Europe, Latin America, and the
Middle East and Africa
▪ It is strengthening its business operations by expanding its
presence in emerging markets
Key Insights
Major Market Share
Terumo Fresenius Haemonetics Corporation Others

7. Key Company Profiles

7.1 Fresenius Kabi
Company Name: Fresenius Kabi
Year of Establishment: 1912
Headquarter: Germany
Total Revenue: $xx Bn
Revenue from Apheresis: $y Bn
Website: https://www.fresenius-kabi.com/
Business Overview
Sample
Company at a Glance

Fresenius Kabi (continued)
Sample
Breakdown of net revenue by segment, 2022
Revenues ($Bn), 2021-2030F
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.2 Terumo
Company Name: Terumo BCT, Inc
Headquarter: Japan
Website: https://www.terumo.com/
Sample
Company at a Glance
Business Overview

Terumo (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.3 Haemonetics
Company Name: Haemonetics Corporation
Headquarter: US
Website: https://www.haemonetics.com/
Sample
Company at a Glance
Business Overview

Haemonetics (continued)
▪ In 2021, Haemonetics Corporation announced that it has entered into a definitive agreement to acquire privately-held Cardiva
Medical, Inc., (“Cardiva”) an industry leading manufacturer of vascular closure systems based in Santa Clara, California
▪ In June, 2020, Haemonetics Corporation, announced that it has entered into a definitive agreement to sell its Fajardo, Puerto Rico,
manufacturing operations to GVS, S.p. A, a leading provider of advanced filtration solutions for critical applications
Recent News and Developments
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.4 Macopharma
Company Name: Macopharma
Headquarter: France
Website: https://www.macopharma.com/
Sample
Company at a Glance
Business Overview

Macopharma (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.5 Nigale
Company Name: Sichuan Nigale Biomedical
Co., Ltd.
Headquarter: Sichuan, China
Website: http://en.nigale.cn/
Sample
Company at a Glance
Business Overview

Nigale (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.6 Scinomed
Company Name: Scinomed
Headquarter: UK
Website: https://www.scinomed.com/
Sample
Company at a Glance
Business Overview

Scinomed (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.7 B-Braun
Company Name: B-Braun
Headquarter: Germany
Website: https://www.bbraun.com/en.html
Sample
Company at a Glance
Business Overview

B-Braun (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.8 Asahi Kasei
Company Name: Asahi Kasei Medical Co., Ltd
Headquarter: Japan
Website: https://www.asahi-kasei.com/
Sample
Company at a Glance
Business Overview

Asahi Kasei (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.9 Cerus
Company Name: Cerus
Headquarter: California, US
Website: https://www.cerus.com/
Sample
Company at a Glance
Business Overview

Cerus (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

8. Access and Reimbursement Scenario

8.1 Key Market Access Considerations
▪ Despite the emergence of new revenue channels for the apheresis market, there are numerous challenges present in the landscape,
which could inadvertently narrow growth prospects. A key barrier to growth is the lack of skilled professionals
▪ Recent times have witnessed an epochal scale of technological changes, which has revolutionized the healthcare industry, and, in
turn, its operations
▪ However, scarcity of expert operators leads to an increase in acquisition cost of well-informed resources, which adds up to the
already high cost of apheresis procedures
▪ Healthcare expenses in developed regions such as North America and Europe are offset through government initiatives and
reimbursement programs
▪ However, cost concerns in developing and underdeveloped regions could shrink opportunities for players in the apheresis market,
though these present highly lucrative, yet largely untapped markets.

8.2 General Reimbursement Environment
▪ Governments of North America and Europe are diverting investments towards encouraging the adoption of quality healthcare
through various programs such as Medicare, Medicaid, employee insurance programs, and Veterans Health Administration, which
alleviates high-cost concerns regarding apheresis procedures
▪ Lack of regular blood donors is being countered by private blood collection centres that attract donors through paid plans
▪ In recent times, hospitals are increasing the adoption of apheresis equipment to collect and store required blood components, so
as to reduce dependency on private suppliers and blood collection centres
▪ Scope of coverage in Insurance– all conditions determined to be medically necessary – may vary by insurer, depending on their
methodology and rigor in establishing and updating their coverage policies
▪ Therapeutic apheresis services are often covered by insurers only if the patient meets certain additional laboratory, diagnostic,
and/or clinical criteria
▪ Preauthorization (physician) or precertification (hospital) is commonly required by commercial insurers (HMOs, PPOs, indemnity
plans, point-of-service plans) and Medicaid programs prior to performing therapeutic apheresis procedures
▪ Medicare claims contractors do not require prior authorization. Depending on the procedure and clinical indication, coverage may
variously be based on a Medicare National Coverage Determination (NCD) or a Local Coverage Determination (LCD), or may be
determined on an individual consideration basis

9. Factors Driving Future Growth

9.1 Key Industry Developments of Apheresis Market
▪ High technological prowess coupled with government aid supporting research & development activities is increasing the
concentration of manufacturers in North America
▪ Advancements in the healthcare sector and progressive improvements in the quality of services have been increasing patients’
reliance on hospitals and clinics
▪ Besides this, easy access to advanced apheresis products, on the backdrop of ongoing development initiatives undertaken by
market players, further expands the patient pool in the region
▪ Considering these drivers, North America is expected to lead the growth of the apheresis market, with the regional market registering
a CAGR of ~10% during the forecast period
▪ Among other regions, manufacturers in the apheresis market in Japan are taking the technological approach to foster innovation in
the development of apheresis products, which is anticipated to strengthen the Asia Pacific apheresis market
▪ Though reimbursement scenarios are likely to offer coverage in developing countries in future, it is imperative that market players
adopt a cost-competitive strategy to achieve better penetration rate of products in these regions

9.2 Ongoing clinical trials for Apheresis
▪ According to guidelines for apheresis procedures as provided by the American Society for Apheresis (ASFA), there are over 87
diseases that can be treated using the apheresis procedure as the sole line or as supportive treatment
▪ Manufacturers of apheresis equipment are capitalizing on this opportunity to foster innovation in these products, and validate them
based on evidence to target novel applications
▪ Among other applications, evidence-based use of apheresis procedures for neurological applications is projected to create a
significant revenue stream for the apheresis market
▪ Moreover, increasing use of radiotherapy or chemotherapy and incidence of damaged bone marrow are likely to unlock profitable
avenues from apheresis procedures used for the treatment of cancer
▪ In order to carry out research procedures on the plasma or mononuclear components of blood, it is often necessary to obtain larger
quantities of plasma or mononuclear cells than can be safely obtained by simple phlebotomy. These components can be easily and
safely obtained using apheresis procedures
▪ More recently, results of the phase 2b/3 Alzheimer Management by Albumin Replacement (“AMBAR”) randomized controlled study
tested three plasma exchange treatment arms of albumin and intravenous immunoglobulin replacement compared with a sham
procedure in patients with mild-to-moderate Alzheimer’s disease. Patients treated with plasma exchange performed significantly
better on an Alzheimer’s Disease and had a trend toward better Alzheimer’s Disease Assessment Scale-Cognitive Scale

10. Conclusion

10.Conclusion
1
2
3
5
4
Increasing Demand
Growing demand of different
components of blood along
with rise in prevalence of
chronic disease and trauma
and injury cases are leading to
rising demands for apheresis
Initiatives to increase
Awareness
As there is a lack of awareness
among people for blood
donations, government and
hospitals are rolling out
schemes to attract donors like
paid donations
New Opportunities
New innovations in apheresis
technologies, research and
trials are already going on to
increase the scope of apheresis
in conditions like Alzheimer
Management
Government funding and
Reimbursement
Government of various
countries are funding more on
the healthcare services and
simultaneously increasing the
scope of insurance covers
New Developments
Manufacturing countries like North
America are already leveraging on
the government support to the
healthcare R&D. Countries like
Japan are fostering innovations in
the apheresis market which can
strengthen Asia Pacific market

62 A Sample Report on Report Title I Confidential
Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

The report is prepared
using a proven
methodology and insightful
research
Reliable
The data is prepared by a
team of highly qualified &
experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to confidently
make smarter business and
strategic decisions
Real
Covers everything you
would need to know about
the market including
market size, competitive
analysis & much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors. With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.

Global Apheresis Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Global Apheresis Market Analysis Sample Report

Similar to Global Apheresis Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Global Apheresis Market Analysis Sample Report